https://pubmed.ncbi.nlm.nih.gov/28983350/?dopt=Abstract
GOLPH3 and YB-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer
High GOLPH3 and nuclear/cytoplasmic YB-1 expression correlated with poor prognosis in prostate cancer. Both markers can be promising targets for new treatment...